Cymat Technologies (TSXV:CYM) signed a letter of intent with Rio Tinto Alcan to acquire the latter’s aluminum metal matrix composite technology, including an existing customer base ...

Tilray Medical, a division of Tilray Brands (TSX:TLRY), has become the first company to receive Italian authorization to distribute medical cannabis flower for therapeutic use Tilray is a global ...

MONTRÉAL, June 23, 2025 (GLOBE NEWSWIRE) -- TC Transcontinental (TSX: TCL.A TCL.B) announced today the acquisition of Middleton Group, a provider of retail services and point-of-purchase display ...

Welcome to episode 15 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and Trevor Abes each deliver a 2.5-minute stock pick related to recent news stories with investment ...

Westhaven Gold (TSXV:WHN) intends to raise C$3.16 million through a non-brokered private placement, including expected investments from Eric Sprott and Earthlabs (TSXV:SPOT) Westhaven Gold is a ...

Aurora Cannabis (TSX:ACB) issued a firm denial of recent misinformation circulating online regarding alleged acquisitions and strategic partnerships The company became aware of an article posted on a ...

Whitecap Resources (TSX:WCP) reports its operating and unaudited financial results for Q3 2024 The company exceeded its production expectations on a total basis and on liquids production Production ...

Silicon-based alloy revenue in the first quarter was $90.9 million, an increase of 6.8% over the prior quarter. The average selling price decreased by 1.8% and shipments increased by 8.7% compared to ...

NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Civitas Resources, Inc. (NYSE:CIVI) and certain ...

We changed the address of the Stockhouse website from www.stockhouse.com to stockhouse.com. When this page refreshes you will be logged in with the new address.

MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic ...

On March 5, the Company announced closing of a non-brokered private placement by issuing a total of 11,799,700 units at a price of $0.05CDN per Unit, for total gross proceeds $589,985CDN. Each unit ...